Literature DB >> 14622494

Overactive bladder and men: indications for anticholinergics.

Ricardo R González1, Alexis E Te.   

Abstract

Similar to bladder outlet obstruction (BOO), overactive bladder (OAB) symptoms are very common and increase in prevalence as men age. Whether or not OAB symptoms are thought to be secondary to BOO, the goal of treatment of symptoms should result in an improved quality of life and ultimately prevent clinical deterioration. A common dilemma when treating men with obstruction and OAB is the risk of acute urinary retention or morbidities related to increasing postvoid residuals. In this article, the relationship of OAB to BOO is examined and the role of urodynamics and data on the use of anticholinergics in men with OAB and obstruction are reviewed. An algorithm for managing men with OAB also is proposed. In men with OAB without evidence of obstruction (including OAB after treatment for BOO), first-line medical therapy with anticholinergics is indicated. However, in men with OAB and concomitant BOO, nomogram has been developed to assist in the management of patients at risk for urinary retention. Men with significant obstruction should be appropriately treated to decrease bladder outlet resistance before adding anticholinergics for the treatment of OAB.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14622494     DOI: 10.1007/s11934-003-0022-2

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  30 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

2.  Bladder outflow obstruction--a cause of denervation supersensitivity.

Authors:  M J Speakman; A F Brading; C J Gilpin; J S Dixon; S A Gilpin; J A Gosling
Journal:  J Urol       Date:  1987-12       Impact factor: 7.450

3.  Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings.

Authors:  M J Hyman; A Groutz; J G Blaivas
Journal:  J Urol       Date:  2001-08       Impact factor: 7.450

4.  alpha-Blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it.

Authors:  C Rossi; B B Kortmann; G S Sonke; D L Floratos; L A Kiemeney; H Wijkstra; J J de la ROSETTE
Journal:  J Urol       Date:  2001-01       Impact factor: 7.450

5.  Tamsulosin in men with confirmed bladder outlet obstruction: a clinical and urodynamic analysis from a single centre in New Zealand.

Authors:  E P Arnold
Journal:  BJU Int       Date:  2001-01       Impact factor: 5.588

6.  Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study.

Authors:  Garry Welch; Katie Weinger; Michael J Barry
Journal:  Urology       Date:  2002-02       Impact factor: 2.649

7.  Urodynamic evidence of vesical neck obstruction in men with misdiagnosed chronic nonbacterial prostatitis and the therapeutic role of endoscopic incision of the bladder neck.

Authors:  S A Kaplan; A E Te; B Z Jacobs
Journal:  J Urol       Date:  1994-12       Impact factor: 7.450

8.  Decrease in the autonomic innervation of human detrusor muscle in outflow obstruction.

Authors:  J A Gosling; S A Gilpin; J S Dixon; C J Gilpin
Journal:  J Urol       Date:  1986-08       Impact factor: 7.450

9.  The relationship of detrusor instability and symptoms with objective parameters used for diagnosing bladder outlet obstruction: a prospective study.

Authors:  Bassem S Wadie; El-Husseiny E Ebrahim; Mohamed A Gomha
Journal:  J Urol       Date:  2002-07       Impact factor: 7.450

Review 10.  Overactive bladder in the male patient: bladder, outlet, or both?

Authors:  Khaled F Abdel-Aziz; Gary E Lemack
Journal:  Curr Urol Rep       Date:  2002-12       Impact factor: 2.862

View more
  2 in total

Review 1.  Does anticholinergic medication have a role in treating men with overactive bladder and benign prostatic hyperplasia?

Authors:  Kyu-Sung Lee; Hye Won Lee; Deok Hyun Han
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-01-03       Impact factor: 3.000

Review 2.  Overactive bladder in the male patient: epidemiology, etiology, evaluation, and treatment.

Authors:  William I Jaffe; Alexis E Te
Journal:  Curr Urol Rep       Date:  2005-11       Impact factor: 2.862

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.